发明授权
US08466290B2 STAT3 inhibitor containing quinolinecarboxamide derivative as active ingredient
有权
含有喹啉甲酰胺衍生物的STAT3抑制剂作为活性成分
- 专利标题： STAT3 inhibitor containing quinolinecarboxamide derivative as active ingredient
- 专利标题（中）： 含有喹啉甲酰胺衍生物的STAT3抑制剂作为活性成分
-
申请号： US13003441申请日： 2009-07-10
-
公开(公告)号： US08466290B2公开(公告)日： 2013-06-18
- 发明人: Akira Asai , Kenji Matsuno , Naohisa Ogo , Takane Yokotagawa , Osamu Takahashi , Yasuto Akiyama , Tadashi Ashizawa , Tadashi Okawara
- 申请人： Akira Asai , Kenji Matsuno , Naohisa Ogo , Takane Yokotagawa , Osamu Takahashi , Yasuto Akiyama , Tadashi Ashizawa , Tadashi Okawara
- 申请人地址： JP Mishima-shi JP Tokyo JP Shizuoka JP Kumamoto-shi JP Tokyo
- 专利权人： Pharma IP General Incorporated Association,Pharma Design, Inc.,Shizuoka Prefecture,Kumamoto Health Science University,Kabushiki Kaisha Yakult Honsha
- 当前专利权人： Pharma IP General Incorporated Association,Pharma Design, Inc.,Shizuoka Prefecture,Kumamoto Health Science University,Kabushiki Kaisha Yakult Honsha
- 当前专利权人地址： JP Mishima-shi JP Tokyo JP Shizuoka JP Kumamoto-shi JP Tokyo
- 代理机构： Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- 优先权： JP2008-180433 20080710
- 国际申请： PCT/JP2009/003235 WO 20090710
- 国际公布： WO2010/004761 WO 20100114
- 主分类号： C07D215/38
- IPC分类号： C07D215/38
摘要：
The present invention provides a STATS inhibitor containing as an active ingredient, a quinolinecarboxamide derivative represented by the formula (I) (in the formula, W represents a bond or an alkylene chain; X represents O, S, or NR34; and R1 to R8 and R34 each represent H, halogen, alkyl, phenyl, furyl, thienyl, or the like), or a pharmacologically acceptable salt thereof.
公开/授权文献
信息查询
